secwatch.observer — SEC 8-K summary
======================================

Issuer:     Longboard Pharmaceuticals, Inc. (—)
CIK:        0001832168
Form:       8-K
Filed at:   2023-09-22T23:59:59+00:00
Accession:  0000950170-23-049437
Event type: other
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Longboard Pharmaceuticals amends bylaws to adopt Universal Proxy Rules and DGCL updates
--------------------------------------------------------------------------------

- Board approved amended bylaws effective Sept 21, 2023 to address SEC Universal Proxy Rule 14a-19.
- New rules require nominating stockholders to disclose proxy solicitation intent and provide compliance evidence.
- Clarifies number of nominees cannot exceed directors to be elected; requires non-white proxy card for dissidents.
- Updates include adjournment procedures, delivery of notices, and other administrative changes per DGCL.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1832168/000095017023049437/0000950170-23-049437-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1832168/000095017023049437/lbph-20230921.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-049437

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer